Curcumin in chronic lymphocytic leukemia – A review

Curcumin is a widely researched natural product and is known to possess anti-carcinogenic properties. Chronic lymphocytic leukemia is a type of leukemia that principally affects patients with age higher than 60 years. Since the toxicity of conventional drugs exceeds the benefits of treating this leu...

Full description

Bibliographic Details
Published in:Asian Pacific Journal of Tropical Biomedicine
Main Author: Vagish Kumar Laxman Shanbhag
Format: Article in Journal/Newspaper
Language:English
Published: Wolters Kluwer Medknow Publications 2017
Subjects:
Akt
Online Access:https://doi.org/10.1016/j.apjtb.2017.05.003
https://doaj.org/article/9adae7ca76af45b88e7c03257f4367ae
Description
Summary:Curcumin is a widely researched natural product and is known to possess anti-carcinogenic properties. Chronic lymphocytic leukemia is a type of leukemia that principally affects patients with age higher than 60 years. Since the toxicity of conventional drugs exceeds the benefits of treating this leukemia type, patients are treated only in the advanced symptomatic stages. The current article reviews curcumin, its general actions and targets in cancer, and specifically that of it in chronic lymphocytic leukemia.